Table 4.
Dopamine score | AIC | Parameter estimate | p value |
---|---|---|---|
5-gene score | 200.621 | 1·897 | 0.010 |
4-gene score without DRD1 | 202.871 | 1·785 | 0.030 |
4-gene score without DRD2 | 201.554 | 2·269 | 0.016 |
4-gene score without DRD3 | 198.989 | 2·306 | 0.005 |
4-gene score without COMT | 202.270 | 1·906 | 0.023 |
4-gene score without DAT | 202.568 | 2·121 | 0.026 |
DRD1 only | 204.568 | 4·650 | 0.070 |
DRD2 only | 205.621 | 2·946 | 0.122 |
DRD3 only | 208.455 | 0·343 | 0.858 |
COMT only | 205.722 | 3·710 | 0.128 |
DAT only | 204.096 | 3·630 | 0.056 |
The dependent variable was the change in AHA-units from baseline to after the intervention. Various dopamine gene scores were used as explanatory variables together with age, sex, and BDNF gene score. Dopamine four-gene scores were formed by removing each single-gene contribution, and the contribution of each gene was calculated by using only that single gene in the model. The table shows the Akaike Information Criteria (AIC) for each model (lower values correspond to a better model), coefficient estimates for the dopamine score variables, and corresponding p-values.